$Karen Dineen Wagner, MD, PhD: Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents$

Karen Dineen Wagner, MD, PhD: Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Name: Karen Dineen Wagner, MD, PhD: Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
SKU: 3260
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 1 Articles Tags: bupropion, clonidine, dextroamphetamine, guanfacine, karen-dineen-wagner, medworks-media, methylphenidate, psychopharmacology-bulletin, psychostimulant, tricyclic-antidepressant

Description

Karen Dineen Wagner, MD, PhD: Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Description

Karen Dineen Wagner, MD, PhD

GENERAL PSYCHOPHARMACOLOGY

Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Karen Dineen Wagner, MD, PhD

Antipsychotics Case Study by Yuan-Hwa Chou

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Karen Dineen Wagner, MD, PhD: Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Description

Karen Dineen Wagner, MD, PhD

GENERAL PSYCHOPHARMACOLOGY

Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Karen Dineen Wagner, MD, PhD

Related products

Antipsychotics Case Study by Yuan-Hwa Chou

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki